Industries > Pharma > Ventricular Assist Device Market Report 2021-2031
Ventricular Assist Device Market Report 2021-2031
Forecasts by Product (LVAD, RVAD, BiVAD, TAH), by Type of Flow (Pulsatile, Continuous), by Design, by Application. PLUS Profiles of Leading Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios
Ventricular Assist Device Market-our new study reveals current trends, technological advancements, and predicted revenues
Where the Ventricular Assist Device market is heading? If you are involved in this industry you must read this newly updated report. Visiongain’s report shows you the potential revenue streams to 2031, assessing data, trends, opportunities and business prospects there.
Discover how to stay ahead
Our 180+ page report provides 150+ tables, 150+ charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our study lets you assess forecasted sales at overall world market and regional level. See financial performance of companies, trends, opportunities, and revenue growth. Much opportunity remains in this growing Ventricular Assist Device market. See how to exploit the opportunities.
Forecasts to 2031 and other analyses reveal the commercial prospects
– In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares, key player positioning, and an exhaustive product portfolio comparison of key vendors
– You find original analyses, with business outlooks and developments which would be useful to tap potential business areas for key players
– Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges, SWOT analysis), product profiles and commercial developments.
Report Scope
Global Ventricular Assist Device market 2021-2031 is segmented on the basis of Application, Product, Type and Geography.
• Revenue and growth forecasts from 2021 to 2031 for the Global Ventricular Assist Device Market by Product:
–Left ventricular assist devices
–Right ventricular assist devices
– Bi-ventricular assist devices
–Total artificial heart
• Revenue and growth forecasts from 2021 to 2031 for the Global Ventricular Assist Device Market by Type:
–Pulsatile flow
–Continuous flow
• Revenue and growth forecasts from 2021 to 2031 for the Global Ventricular Assist Device Market by Application:
– Bridge to transplantation
– Destination therapy
– Bridge to recovery & Bridge to candidacy
• Revenue and growth forecasts from 2021 to 2031 for the Global Ventricular Assist Device Market by Region:
– North America: US, Canada
– Europe: Germany, UK, Italy, France, Spain, Rest of Europe
– Asia-Pacific: China, India, Japan, Australia, Rest of Asia-Pacific
– Latin America: Brazil, Mexico, and Rest of Latin America
– Middle East & Africa: GCC, South Africa, Rest of MEA
• Our study discusses the selected leading companies that are the major players in the Ventricular Assist Device industry:
– Abiomed
– Medtronic
– Abbott
– Berlin Heart
– Cardiac Assist, Inc.
– Jarvik Heart, Inc.
– ReliantHeart, Inc.
– Sun Medical Technology Research Corp.
– KOL Commentary
How the Ventricular Assist Device Market report helps you
In summary, our 190+ page report provides you with the following knowledge:
– Revenue forecasts to 2031 for each of the above mentioned segments each forecasted at a global and regional level– growth of all segments on regional level helps to understand most lucrative segment.
– Revenue forecasts to 2031 for 5 regional and 10 key national markets – the report highlights market growth prospects for key countries such as the U.S., Canada, Germany, UK, France, Italy, Spain, China, Japan, and India. The report also highlights growth potential in Central & South America as well as Middle East & Africa.
– Prospects for established firms and those seeking to enter the market– including company profiles for over 10 of the major companies involved in the Ventricular Assist Device market
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
COVID 19 Impact & Recovery Analysis on the Market
Currently, COVID-19 (Coronavirus) is prevalent across the globe. Many companies are underway to discover a vaccine, or therapeutics which can prevent or cure the COVID-19 virus. According to the World Health Organization, as of 13th September 2020, there were over 28,637,952 confirmed cases of COVID-19, with more than 917,417 deaths, globally.
The COVID-19 disease is continuously disrupting the growth of various markets. However, the immediate effect of the pandemic is different. Some industries will register a drop in demand, various other markets will remain unchanged and display a promising growth opportunities. The healthcare centers, such as hospitals and diagnostic labs, have been investing heavily in maintaining the supply of essential equipment and drugs. Due to lockdown across the globe, people were unable to reach healthcare facilities and non-urgent procedures were advised to put hold which impacted the healthcare industry a lot.
Due to COVID 19 pandemic patients were reluctant in visiting hospitals or clinics for their treatments and preferred virtual doctor visits. Lockdown across the globe due to the pandemic led to the delay of procedures which were not urgent. These factors negatively impacted the ventricular assist device market for limited period of time. However, slowly the situation is getting back to normal everywhere and the market discussed is expected to increase in future.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Ventricular Assist Device market and leading companies. You will find data, trends and predictions.
The Ventricular Assist Device Market 2021-2031 report will be of value to anyone who wants to better understand the market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the Ventricular Assist Device industry.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Ventricular Assist Device Market Report 2021-2031: Forecasts by Product (LVAD, RVAD, BiVAD, TAH), by Type of Flow (Pulsatile, Continuous), by Design, by Application. PLUS Profiles of Leading Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated VISIONGAIN Reports
1.8. About VISIONGAIN
2. Introduction to the Ventricular Assist Device Market
2.1. Ventricular Assist Device Market Definition
2.2. Application Submarkets Definitions
2.3. Component Submarkets Definitions
2.4. Mode Submarkets Definitions
3. Ventricular Assist Device Market Overview
3.1. Global Ventricular Assist Device Market Size and Forecast by Region
3.2. Global Ventricular Assist Device Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Cumulative occurrence of circulatory diseases
3.3.2. Market Restraints/Challenges
3.3.2.1. Huge procedure price
3.3.3. Opportunities
3.3.4. Global Ventricular Assist Device Market: Trends
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weaknesses
3.4.3. Opportunities
3.4.4. Threats
3.5. Porter’s Five Forces Analysis
3.5.1. Competitive Rivalry
3.5.2. Supplier Power
3.5.3. Buyer Power
3.5.4. Threat of Substitution
3.5.5. Threat of New Entry
4. Global Ventricular Assist Device Market Analysis and Forecast 2021-2031, by Product (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.2. Left Ventricular Assist Device
4.3. Right Ventricular Assist Device
4.4. Bi-ventricular assist device
4.5. Total Artificial Heart
5. Global Ventricular Assist Device Market Analysis and Forecast, 2021-2031 byType of FlowEstimates (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.2. Pulsatile flow
5.3. Continuous flow
6. Global Ventricular Assist Device Market Analysis and Forecast, 2021-2031 byApplication (Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.2. Bridge to Transplantation
6.3. Destination Therapy
6.4. Bridge to recovery & Bridge to Candidacy
7. North America Ventricular Assist Device Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.2. North America Ventricular Assist Device Market Size and Forecast byProduct
7.3. North America Ventricular Assist Device Market Size and Forecast byType of Flow Estimates
7.4. North America Ventricular Assist Device Market Size and Forecast byApplication
7.5. U.S. Ventricular Assist Device Market
7.6. Canada Ventricular Assist Device Market
8. Europe Ventricular Assist Device Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.2. Europe Ventricular Assist Device Market Size and Forecast byProduct
8.3. Europe Ventricular Assist Device Market Size and Forecast byType of Flow Estimates
8.4. Europe Ventricular Assist Device Market Size and Forecast by Application
8.5. UK Ventricular Assist Device Market
8.6. Germany Ventricular Assist Device Market
8.7. France Ventricular Assist Device Market
8.8. Rest of Europe Ventricular Assist Device Market
9. Asia Pacific Ventricular Assist Device Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. Asia Pacific Ventricular Assist Device Market Size and Forecast by Product
9.3. Asia Pacific Ventricular Assist Device Market Size and Forecast by Type of Flow Estimates
9.4. Asia Pacific Ventricular Assist Device Market Size and Forecast by Application
9.5. China Ventricular Assist Device Market
9.6. India Ventricular Assist Device Market
9.7. Japan Ventricular Assist Device Market
9.8. Rest of Asia Pacific Ventricular Assist Device Market
10. Latin America Ventricular Assist Device Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. Latin America Ventricular Assist Device Market Size and Forecast by Product
10.3. Latin America Ventricular Assist Device Market Size and Forecast by Type of Flow Estimates
10.4. Latin America Ventricular Assist Device Market Size and Forecast by Application
10.5. Brazil Ventricular Assist Device Market
10.6. Mexico Ventricular Assist Device Market
10.7. Rest of Latin America Ventricular Assist Device Market
11. MEA Ventricular Assist Device Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. MEA Ventricular Assist Device Market Size and Forecast by Product
11.3. MEA Ventricular Assist Device Market Size and Forecast by Type of Flow Estimates
11.4. MEA Ventricular Assist Device Market Size and Forecast by Application
11.5. GCC Ventricular Assist Device Market
11.6. South Africa Ventricular Assist Device Market
11.7. Rest of MEA Ventricular Assist Device Market
12. Companies in the Ventricular Assist Device Market
12.1. Abiomed
12.1.1. Company Snapshot
12.1.2. Company Overview
12.1.3. Financial Performance (2015-2019)
12.1.3.1. Net Revenue
12.1.3.2. Gross Profit
12.1.3.3. Geographical Revenue, 2019
12.1.4. Product Offerings
12.1.5. Recent Initiatives (2017-2019)
12.2. Medtronic
12.2.1. Company Snapshot
12.2.2. Company Overview
12.2.3. Financial Performance (2015-2019)
12.2.3.1. Net Revenue
12.2.3.2. Gross Profit
12.2.3.3. Geographical Revenue, 2019
12.2.4. Product Offerings
12.2.5. Recent Initiatives (2017-2019)
12.3. Abbott
12.3.1. Company Snapshot
12.3.2. Company Overview
12.3.3. Financial Performance (2015-2019)
12.3.3.1. Net Revenue
12.3.3.2. Gross Profit
12.3.3.3. Geographical Revenue, 2019
12.3.4. Product Offerings
12.3.5. Recent Initiatives (2017-2019)
12.4. Berlin Heart.
12.4.1. Company Snapshot
12.4.2. Company Overview
12.4.3. Financial Performance (2015-2019)
12.4.3.1. Net Revenue
12.4.3.2. Gross Profit
12.4.3.3. Geographical Revenue, 2019
12.4.4. Product Offerings
12.4.5. Recent Initiatives (2017-2019)
12.5. Cardiac Assist, Inc
12.5.1. Company Snapshot
12.5.2. Company Overview
12.5.3. Financial Performance (2015-2019)
12.5.3.1. Net Revenue
12.5.3.2. Gross Profit
12.5.3.3. Geographical Revenue, 2019
12.5.4. Product Offerings
12.5.5. Recent Initiatives (2017-2019)
12.6. Jarvik Heart, Inc.
12.6.1. Company Snapshot
12.6.2. Company Overview
12.6.3. Financial Performance (2015-2019)
12.6.3.1. Net Revenue
12.6.3.2. Gross Profit
12.6.3.3. Geographical Revenue, 2019
12.6.4. Product Offerings
12.6.5. Recent Initiatives (2017-2019)
12.7. ReliantHeart, Inc.
12.7.1. Company Snapshot
12.7.2. Company Overview
12.7.3. Financial Performance (2015-2019)
12.7.3.1. Net Revenue
12.7.3.2. Gross Profit
12.7.3.3. Geographical Revenue, 2019
12.7.4. Product Offerings
12.7.5. Recent Initiatives (2017-2019)
12.8. Sun Medical Technology Research Corp.
12.8.1. Company Snapshot
12.8.2. Company Overview
12.8.3. Financial Performance (2015-2019)
12.8.3.1. Net Revenue
12.8.3.2. Gross Profit
12.8.3.3. Geographical Revenue, 2019
12.8.4. Product Offerings
12.8.5. Recent Initiatives (2017-2019)
12.9. Other Notable Players
13. Conclusion
14. Glossary
Associated VISIONGAIN Reports
VISIONGAIN Report Sales Order Form
Appendix A
About VISIONGAIN
Appendix B
VISIONGAIN report evaluation form
LIST OF TABLES
Table No 1: Ventricular Assist Device Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table No 2: Ventricular Assist Device Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table No 3: Ventricular Assist Device Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table No 4: Ventricular Assist Device Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table No 5: Ventricular Assist Device Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table No 6: Ventricular Assist Device Market Drivers & Restraints 2020
Table No 7: Ventricular Assist Device Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 8: Ventricular Assist Device Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 9: Ventricular Assist Device Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 10: Ventricular Assist Device Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 11: Ventricular Assist Device Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 12: Left Ventricular Assist Device Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table No 13: Left Ventricular Assist Device Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table No 14: Left Ventricular Assist Device Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table No 15: Left Ventricular Assist Device Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table No 16: Left Ventricular Assist Device Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table No 17: Right Ventricular Assist Device Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table No 18: Right Ventricular Assist Device Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table No 19: Right Ventricular Assist Device Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table No 20: Right Ventricular Assist Device Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table No 21: Right Ventricular Assist Device Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table No 22: Bi-ventricular assist device Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table No 23: Bi-ventricular assist device Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table No 24: Bi-ventricular assist device Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table No 25: Bi-ventricular assist device Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table No 26: Bi-ventricular assist device Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table No 27: Total Artificial Heart Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table No 28: Total Artificial Heart Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table No 29: Total Artificial Heart Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table No 30: Total Artificial Heart Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table No 31: Total Artificial Heart Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table No 32: Ventricular Assist Device Forecast by Type of Flow Estimates 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 33: Ventricular Assist Device Forecast by Type of Flow Estimates 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 34: Ventricular Assist Device Forecast by Type of Flow Estimates 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 35: Ventricular Assist Device Forecast by Type of Flow Estimates 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 36: Ventricular Assist Device Forecast by Type of Flow Estimates 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 37: Pulsatile flow Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table No 38: Pulsatile flow Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table No 39: Pulsatile flow Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table No 40: Pulsatile flow Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table No 41: Pulsatile flow Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table No 42: Continuous flow Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table No 43: Continuous flow Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table No 44: Continuous flow Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table No 45: Continuous flow Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table No 46: Continuous flow Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table No 47: Ventricular Assist Device Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 48: Ventricular Assist Device Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 49: Ventricular Assist Device Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 50: Ventricular Assist Device Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 51: Ventricular Assist Device Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 52: Bridge to Transplantation Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table No 53: Bridge to Transplantation Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table No 54: Bridge to Transplantation Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table No 55: Bridge to Transplantation Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table No 56: Bridge to Transplantation Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table No 57: Home care settings Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table No 58: Home care settings Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table No 59: Home care settings Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table No 60: Home care settings Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table No 61: Home care settings Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table No 62: Destination Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table No 63: Destination Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table No 64: Destination Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table No 65: Destination Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table No 66: Destination Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table No 67: Bridge to recovery & Bridge to candidacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table No 68: Bridge to recovery & Bridge to candidacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table No 69: Bridge to recovery & Bridge to candidacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table No 70: Bridge to recovery & Bridge to candidacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table No 71: Bridge to recovery & Bridge to candidacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table No 72: Regional Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 73: Regional Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 74: Regional Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 75: Regional Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 76: Regional Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 77: North America Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 78: North America Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 79: North America Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 80: North America Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 81: North America Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 82: North America Ventricular Assist Device Market Forecast by Type of Flow Estimates 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 83: North America Ventricular Assist Device Market Forecast by Type of Flow Estimates 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 84: North America Ventricular Assist Device Market Forecast by Type of Flow Estimates 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 85: North America Ventricular Assist Device Market Forecast by Type of Flow Estimates 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 86: North America Ventricular Assist Device Market Forecast by Type of Flow Estimates 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 87: North America Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 88: North America Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 89: North America Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 90: North America Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 91: North America Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 92: US Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 93: US Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 94: US Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 95: US Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 96: US Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 97: Canada Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 98: Canada Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 99: Canada Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 100: Canada Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 101: Canada Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 102: Europe Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 103: Europe Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 104: Europe Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 105: Europe Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 106: Europe Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 107: Europe Ventricular Assist Device Market Forecast by Type of Flow Estimates 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 108: Europe Ventricular Assist Device Market Forecast by Type of Flow Estimates 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 109: Europe Ventricular Assist Device Market Forecast by Type of Flow Estimates 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 110: Europe Ventricular Assist Device Market Forecast by Type of Flow Estimates 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 111: Europe Ventricular Assist Device Market Forecast by Type of Flow Estimates 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 112: Europe Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 113: Europe Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 114: Europe Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 115: Europe Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 116: Europe Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 117: UK Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 118: UK Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 119: UK Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 120: UK Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 121: UK Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 122: Germany Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 123: Germany Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 124: Germany Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 125: Germany Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 126: Germany Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 127: France Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 128: France Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 129: France Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 130: France Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 131: France Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 132: Rest of Europe Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 133: Rest of Europe Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 134: Rest of Europe Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 135: Rest of Europe Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 136: Rest of Europe Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 137: Asia Pacific Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 138: Asia Pacific Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 139: Asia Pacific Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 140: Asia Pacific Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 141: Asia Pacific Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 142: Asia Pacific Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 143: Asia Pacific Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 144: Asia Pacific Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 145: Asia Pacific Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 146: Asia Pacific Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 147: Asia Pacific Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 148: Asia Pacific Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 149: Asia Pacific Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 150: Asia Pacific Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 151: Asia Pacific Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 152: China Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 153: China Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 154: China Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 155: China Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 156: China Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 157: India Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 158: India Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 159: India Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 160: India Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 161: India Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 162: Japan Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 163: Japan Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 164: Japan Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 165: Japan Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 166: Japan Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 167: RoAPAC Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 168: RoAPAC Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 169: RoAPAC Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 170: RoAPAC Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 171: RoAPAC Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 172: Latin America Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 173: Latin America Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 174: Latin America Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 175: Latin America Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 176: Latin America Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 177: Latin America Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 178: Latin America Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 179: Latin America Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 180: Latin America Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 181: Latin America Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 182: Latin America Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 183: Latin America Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 184: Latin America Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 185: Latin America Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 186: Latin America Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 187: Brazil Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 188: Brazil Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 189: Brazil Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 190: Brazil Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 191: Brazil Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 192: Mexico Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 193: Mexico Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 194: Mexico Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 195: Mexico Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 196: Mexico Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 197: Rest of Latin America Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 198: Rest of Latin America Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 199: Rest of Latin America Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 200: Rest of Latin America Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 201: Rest of Latin America Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 202: Middle East Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 203: Middle East Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 204: Middle East Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 205: Middle East Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 206: Middle East Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 207: Middle East Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 208: Middle East Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 209: Middle East Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 210: Middle East Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 211: Middle East Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 212: Middle East Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 213: Middle East Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 214: Middle East Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 215: Middle East Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 216: Middle East Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 217: GCC Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 218: GCC Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 219: GCC Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 220: GCC Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 221: GCC Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 222: South Africa Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 223: South Africa Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 224: South Africa Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 225: South Africa Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 226: South Africa Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 227: Rest of MEA Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 228: Rest of MEA Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 229: Rest of MEA Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 230: Rest of MEA Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 231: Rest of MEA Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 232: Leading 10 Ventricular Assist Device Market Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table No 233: Abiomed Profile (CEO, HQ, Founded, Website)
Table No 234: Abiomed (Total Company Sales 2016-2019 (US$mn, AGR %)
Table No 235: Abiomed (Net Income 2016-2019 (US$mn, AGR %)
Table No 236: Medtronic Profile (CEO, HQ, Founded, Website)
Table No 237: Medtronic (Total Company Sales 2016-2019 (US$mn, AGR %)
Table No 238: Medtronic (Net Income 2016-2019 (US$mn, AGR %)
Table No 239: Abbott. Profile (CEO, HQ, Founded, Website)
Table No 240: Abbott. (Total Company Sales 2016-2019 (US$mn, AGR %)
Table No 241: Abbott. (Net Income 2016-2019 (US$mn, AGR %)
Table No 242: Berlin Heart Profile (CEO, HQ, Founded, Website)
Table No 243: Berlin Heart (Total Company Sales 2016-2019 (US$mn, AGR %)
Table No 244: Berlin Heart (Net Income 2016-2019 (US$mn, AGR %))
Table No 245: Cardiac Assist, Inc Profile (CEO, HQ, Founded, Website)
Table No 246: Cardiac Assist, Inc (Total Company Sales 2016-2019 (US$mn, AGR %)
Table No 247: Cardiac Assist, Inc (Net Income 2016-2019 (US$mn, AGR %))
Table No 248: Jarvik Heart, Inc Profile (CEO, HQ, Founded, Website)
Table No 249: Jarvik Heart, Inc (Total Company Sales 2016-2019 (US$mn, AGR %))
Table No 250: Jarvik Heart, Inc (Net Income 2016-2019 (US$mn, AGR %))
Table No 251: ReliantHeart, Inc. Profile (CEO, HQ, Founded, Website)
Table No 252: ReliantHeart, Inc. (Total Company Sales 2016-2019 (US$mn, AGR %))
Table No 253: ReliantHeart, Inc. (Net Income 2016-2019 (US$mn, AGR %))
Table No 254: Sun Medical Technology Research Corp Profile (CEO, HQ, Founded, Website)
Table No 255: Sun Medical Technology Research Corp (Total Company Sales 2016-2019 (US$mn, AGR %))
Table No 256: Sun Medical Technology Research Corp (Net Income 2016-2019 (US$mn, AGR %))
Table No 257: Other Companies Ventricular Assist Device Market 2020 (Company, Location)
LIST OF FIGURES
Figure No 1: Ventricular Assist Device Market Product Overview
Figure No 2: Ventricular Assist Device Market Type of Flow Estimatesr Overview
Figure No 3: Ventricular Assist Device Market Application Overview
Figure No 4: Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure No 5: Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 6: Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 7: Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 8: Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 9: Ventricular Assist Device Submarket Forecast by Product 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure No 10: Ventricular Assist Device Submarket Forecast by Product 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure No 11: Ventricular Assist Device Submarket Forecast by Product 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure No 12: Ventricular Assist Device Submarket Forecast by Product 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure No 13: Ventricular Assist Device Submarket Forecast by Product 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure No 14: Left Ventricular Assist Device 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure No 15: Left Ventricular Assist Device 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure No 16: Left Ventricular Assist Device 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure No 17: Left Ventricular Assist Device 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure No 18: Left Ventricular Assist Device 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure No 19: Right Ventricular Assist Device Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure No 20: Right Ventricular Assist Device Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure No 21: Right Ventricular Assist Device Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure No 22: Right Ventricular Assist Device Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure No 23: Right Ventricular Assist Device Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure No 24: Bi-ventricular assist device Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure No 25: Bi-ventricular assist device Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure No 26: Bi-ventricular assist device Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure No 27: Bi-ventricular assist device Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure No 28: Bi-ventricular assist device Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure No 29: Total Artificial Heart Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure No 30: Total Artificial Heart Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure No 31: Total Artificial Heart Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure No 32: Total Artificial Heart Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure No 33: Total Artificial Heart Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure No 34: Ventricular Assist Device Submarket Forecast by Type of Flow Estimates 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure No 35: Ventricular Assist Device Submarket Forecast by Type of Flow Estimates 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure No 36: Ventricular Assist Device Submarket Forecast by Type of Flow Estimates 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure No 37: Ventricular Assist Device Submarket Forecast by Type of Flow Estimates 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure No 38: Ventricular Assist Device Submarket Forecast by Type of Flow Estimates 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure No 39: Pulsatile flow Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure No 40: Pulsatile flow Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure No 41: Pulsatile flow Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure No 42: Pulsatile flow Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure No 43: Pulsatile flow Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure No 44: Continuous flow Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure No 45: Continuous flow Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure No 46: Continuous flow Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure No 47: Continuous flow Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure No 48: Continuous flow Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure No 49: Ventricular Assist Device Submarket Forecast by Application 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure No 50: Ventricular Assist Device Submarket Forecast by Application 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure No 51: Ventricular Assist Device Submarket Forecast by Application 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure No 52: Ventricular Assist Device Submarket Forecast by Application 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure No 53: Ventricular Assist Device Submarket Forecast by Application 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure No 54: Bridge to Transplantation Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure No 55: Bridge to Transplantation Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure No 56: Bridge to Transplantation Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure No 57: Bridge to Transplantation Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure No 58: Bridge to Transplantation Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure No 59: Destination Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure No 60: Destination Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure No 61: Destination TherapySubmarket Forecast 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure No 62: Destination Therapy Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure No 63: Destination Therapy Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure No 64: Bridge to recovery & Bridge to Candidacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure No 65: Bridge to recovery & Bridge to Candidacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure No 66: Bridge to recovery & Bridge to Candidacy Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure No 67: Bridge to recovery & Bridge to Candidacy Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure No 68: Bridge to recovery & Bridge to Candidacy Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure No 69: Regional Ventricular Assist Device Market Forecast 2021-2031 (Sales US$M, Global AGR %)
Figure No 70: Regional Ventricular Assist Device Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario V)
Figure No 71: Regional Ventricular Assist Device Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario U)
Figure No 72: Regional Ventricular Assist Device Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario W)
Figure No 73: Regional Ventricular Assist Device Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario L)
Figure No 74: North America Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M, AGR %) (Before COVID)
Figure No 75: North America Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 76: North America Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 77: North America Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 78: North America Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 79: North America Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M, AGR %)
Figure No 80: North America Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 81: North America Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 82: North America Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 83: North America Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 84: North America Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %)
Figure No 85: North America Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 86: North America Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 87: North America Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 88: North America Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 89: US Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure No 90: US Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 91: US Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 92: US Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 93: US Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 94: Canada Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %)
Figure No 95: Canada Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 96: Canada Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 97: Canada Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 98: Canada Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 99: Europe Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M) (Before COVID)
Figure No 100: Europe Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario V)
Figure No 101: Europe Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario U)
Figure No 102: Europe Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario W)
Figure No 103: Europe Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario L)
Figure No 104: Europe Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M) (Before COVID)
Figure No 105: Europe Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M) (COVID - Scenario V)
Figure No 106: Europe Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M) (COVID - Scenario U)
Figure No 107: Europe Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M) (COVID - Scenario W)
Figure No 108: Europe Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M) (COVID - Scenario L)
Figure No 109: Europe Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %)
Figure No 110: Europe Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 111: Europe Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 112: Europe Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 113: Europe Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 114: UK Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure No 115: UK Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 116: UK Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 117: UK Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 118: UK Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 119: Germany Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %)
Figure No 120: Germany Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 121: Germany Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 122: Germany Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 123: Germany Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 124: France Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %)
Figure No 125: France Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 126: France Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 127: France Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 128: France Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 129: Rest of Europe Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure No 130: Rest of Europe Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 131: Rest of Europe Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 132: Rest of Europe Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 133: Rest of Europe Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 134: Asia-Pacific Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M) (Before COVID)
Figure No 135: Asia-Pacific Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario V)
Figure No 136: Asia-Pacific Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario U)
Figure No 137: Asia-Pacific Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario W)
Figure No 138: Asia-Pacific Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario L)
Figure No 139: Asia-Pacific Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M)
Figure No 140: Asia-Pacific Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M) (COVID - Scenario V)
Figure No 141: Asia-Pacific Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M) (COVID - Scenario U)
Figure No 142: Asia-Pacific Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M) (COVID - Scenario W)
Figure No 143: Asia-Pacific Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M) (COVID - Scenario L)
Figure No 144: Asia-Pacific Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %)
Figure No 145: Asia-Pacific Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 146: Asia-Pacific Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 147: Asia-Pacific Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 148: Asia-Pacific Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 149: China Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %)
Figure No 150: China Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 151: China Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 152: China Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 153: China Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 154: India Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %)
Figure No 155: India Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 156: India Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 157: India Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 158: India Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 159: Japan Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure No 160: Japan Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 161: Japan Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 162: Japan Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 163: Japan Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 164: Rest of APAC Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure No 165: Rest of APAC Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 166: Rest of APAC Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 167: Rest of APAC Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 168: Rest of APAC Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 169: Latin America Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M)
Figure No 170: Latin America Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario V)
Figure No 171: Latin America Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario U)
Figure No 172: Latin America Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario W)
Figure No 173: Latin America Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario L)
Figure No 174: Latin America Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M)
Figure No 175: Latin America Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M) (COVID - Scenario V)
Figure No 176: Latin America Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M) (COVID - Scenario U)
Figure No 177: Latin America Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M) (COVID - Scenario W)
Figure No 178: Latin America Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M) (COVID - Scenario L)
Figure No 179: Latin America Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M)
Figure No 180: Latin America Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M) (COVID - Scenario V)
Figure No 181: Latin America Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M) (COVID - Scenario U)
Figure No 182: Latin America Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M) (COVID - Scenario W)
Figure No 183: Latin America Ventricular Assist Device Market Forecast by Application 2021-2031 (US$M) (COVID - Scenario L)
Figure No 184: Brazil Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure No 185: Brazil Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 186: Brazil Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 187: Brazil Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 188: Brazil Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 189: Mexico Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure No 190: Mexico Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 191: Mexico Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 192: Mexico Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 193: Mexico Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 194: Rest of Latin America Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure No 195: Rest of Latin Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 196: Rest of Latin Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 197: Rest of Latin Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 198: Rest of Latin Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 199: Middle East Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M) (Before COVID)
Figure No 200: Middle East Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario V)
Figure No 201: Middle East Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario U)
Figure No 202: Middle East Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario W)
Figure No 203: Middle East Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario L)
Figure No 204: Middle East Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M) (Before COVID)
Figure No 205: Middle East Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M) (COVID - Scenario V)
Figure No 206: Middle East Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M) (COVID - Scenario U)
Figure No 207: Middle East Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M) (COVID - Scenario W)
Figure No 208: Middle East Ventricular Assist Device Market Forecast by Type of Flow Estimatesr 2021-2031 (US$M) (COVID - Scenario L)
Figure No 209: Middle East Ventricular Assist Device Market Forecast by Applicationr 2021-2031 (US$M) (Before COVID)
Figure No 210: Middle East Ventricular Assist Device Market Forecast by Applicationr 2021-2031 (US$M) (COVID - Scenario V)
Figure No 211: Middle East Ventricular Assist Device Market Forecast by Applicationr 2021-2031 (US$M) (COVID - Scenario U)
Figure No 212: Middle East Ventricular Assist Device Market Forecast by Applicationr 2021-2031 (US$M) (COVID - Scenario W)
Figure No 213: Middle East Ventricular Assist Device Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario L)
Figure No 214: GCC Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure No 215: GCC Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 216: GCC Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 217: GCC Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 218: GCC Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 219: South Africa Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure No 220: South Africa Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 221: South Africa Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 222: South Africa Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 223: South Africa Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 224: Rest of MEA Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure No 225: Rest of MEA Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 226: Rest of MEA Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 227: Rest of MEA Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 228: Rest of MEA Ventricular Assist Device Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 229: Abiomed (Total Company Sales 2016-2019 (US$mn, AGR %)
Figure No 230: Abiomed (Net Income 2016-2019 (US$mn, AGR %)
Figure No 231: Medtronic (Total Company Sales 2016-2019 (US$mn, AGR %)
Figure No 232: Medtronic (Net Income 2016-2019 (US$mn, AGR %)
Figure No 233: Abbott (Total Company Sales 2016-2019 (US$mn, AGR %)
Figure No 234: Abbott (Net Income 2016-2019 (US$mn, AGR %)
Figure No 235: Berlin Heart (Total Company Sales 2016-2019 (US$mn, AGR %)
Figure No 236: Berlin Heart (Net Income 2016-2019 (US$mn, AGR %))
Figure No 237: Cardiac Assist, Inc (Total Company Sales 2016-2019 (US$mn, AGR %)
Figure No 238: Cardiac Assist, Inc (Net Income 2016-2019 (US$mn, AGR %))
Figure No 239: Jarvik Heart, Inc (Total Company Sales 2016-2019 (US$mn, AGR %))
Figure No 240: Jarvik Heart, Inc (Net Income 2016-2019 (US$mn, AGR %))
Figure No 241: ReliantHeart, Inc. (Total Company Sales 2016-2019 (US$mn, AGR %))
Figure No 242: ReliantHeart, Inc. (Net Income 2016-2019 (US$mn, AGR %))
Figure No 243: Sun Medical Technology Research Corp (Total Company Sales 2016-2019 (US$mn, AGR %))
Figure No 244: Sun Medical Technology Research Corp (Net Income 2016-2019 (US$mn, AGR %))
Companies Profiled in the Report
1.Abiomed
2.Medtronic
3. Abbott
4. Berlin Heart
5. Cardiac Assist, Inc.
6. Jarvik Heart, Inc.
7.ReliantHeart, Inc.
8. Sun Medical Technology Research Corp.
List of Companies Mentioned in the Report:
1. Asahi Kasei Corporation
2. Key strategic moves and developments
3. Calon Cardio-Technology Ltd.
4. Terumo Corporation
5. Abiomed
6. Medtronic
7. Abbott
8. Berlin Heart
9. Cardiac Assist, Inc.
10. Jarvik Heart, Inc.
11. .ReliantHeart, Inc.
12. Sun Medical Technology Research Corp.
List of Organizations Mentioned in the Report:
• Food and Drugs Administration
• American Cancer Society
• World Health Organization
• American Hospital Association (AHA)
• National Cancer Institute
• NIH
• CDC
• Mayo Clinic
Download sample pages
Complete the form below to download your free sample pages for Ventricular Assist Device Market Report 2021-2031Download sample pages
Complete the form below to download your free sample pages for Ventricular Assist Device Market Report 2021-2031Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
If so, please drop an email to Sara Peerun stating your chosen report title to sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Deep Frozen Packaging Logistics Market Report 2023-2033
The global Deep Frozen Packaging Logistics market was valued at US$21,088.3 million in 2022 and is projected to grow at a CAGR of 7.7% during the forecast period 2023-2033.
29 March 2023
Visiongain Publishes Automation in Biopharma Industry Market Report 2023-2033
The global Automation in Biopharma Industry market was valued at US$1,784.1 million in 2022 and is projected to grow at a CAGR of 5.7% during the forecast period 2023-2033.
20 March 2023
Visiongain Publishes eClinical Solutions Market Report 2023-2033
The global eClinical Solutions market was valued at US$8.03 billion in 2022 and is projected to grow at a CAGR of 13.09% during the forecast period 2023-2033.
17 March 2023
Visiongain Publishes Therapeutic Respiratory Devices Market Report 2023-2033
The global Therapeutic Respiratory Devices market was valued at US$59.49 billion in 2022 and is projected to grow at a CAGR of 8.02% during the forecast period 2023-2033.
15 March 2023
